Astrana Health, Inc. (ASTH) tracked by StreetAlpha. ASTH reports earnings on Thu, Nov 5, 2026. The average 12-month price target from 4 analysts is $52.75, with a high of $55.00 and a low of $50.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (4 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in ASTH, 0% of them bullish and 100% bearish.
Each firm's latest rating on ASTH in the past 90 days
Average 12-month target
$52.75
Based on 4 analysts who set a price target on ASTH in the past 90 days. The average target is $52.75, with a high of $55.00 and a low of $50.00.
Low $50.00Avg $52.75High $55.00
Highest target$55.00
Average target$52.75
Lowest target$50.00
Latest rating changes
Freedom Capital MarketsMaintained
Oct 1Buy$50
OppenheimerInitiated
Sep 15Buy$53
Truist SecuritiesMaintained
Aug 11Buy$55
BarclaysTarget raised
Aug 7Buy$50 → $53
TD CowenMaintained
Jul 14Buy$50
Date
Firm
Action
Rating
Price target
Oct 1
Freedom Capital Markets
Maintained
Buy
$50
Sep 15
Oppenheimer
Initiated
Buy
$53
Aug 11
Truist Securities
Maintained
Buy
$55
Aug 7
Barclays
Target raised
Buy
$50 → $53
Jul 14
TD Cowen
Maintained
Buy
$50
Loading…
Whale Options Flow
90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Jul 20 – Jul 20
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ASTH is in one of them and how their past ASTH trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
